Grasso L - Search Results

1

Treatment of Acromegalic Osteopathy in Real-life Clinical Practice: The BAAC (Bone Active Drugs in Acromegaly) Study.

Mazziotti G, Battista C, Maffezzoni F, Chiloiro S, Ferrante E, Prencipe N, Grasso L, Gatto F, Olivetti R, Arosio M, Barale M, Bianchi A, Cellini M, Chiodini I, De Marinis L, Del Sindaco G, Di Somma C, Ferlin A, Ghigo E, Giampietro A, Grottoli S, Lavezzi E, Mantovani G, Morenghi E, Pivonello R, Porcelli T, Procopio M, Pugliese F, Scillitani A, Lania AG. Mazziotti G, et al. Among authors: grasso l. J Clin Endocrinol Metab. 2020 Sep 1;105(9):dgaa363. doi: 10.1210/clinem/dgaa363. J Clin Endocrinol Metab. 2020. PMID: 32511698 Free article.

2

The metabolic profile in active acromegaly is gender-specific.

Ciresi A, Amato MC, Pivonello R, Nazzari E, Grasso LF, Minuto F, Ferone D, Colao A, Giordano C. Ciresi A, et al. Among authors: grasso lf. J Clin Endocrinol Metab. 2013 Jan;98(1):E51-9. doi: 10.1210/jc.2012-2896. Epub 2012 Nov 15. J Clin Endocrinol Metab. 2013. PMID: 23162101 Free article.

3

Growth hormone-secreting tumor shrinkage after 3 months of octreotide-long-acting release therapy predicts the response at 12 months.

Colao A, Pivonello R, Auriemma RS, Galdiero M, Savastano S, Grasso LF, Lombardi G. Colao A, et al. J Clin Endocrinol Metab. 2008 Sep;93(9):3436-42. doi: 10.1210/jc.2008-0424. Epub 2008 Jul 1. J Clin Endocrinol Metab. 2008. PMID: 18593770

4

Impact of somatostatin analogs versus surgery on glucose metabolism in acromegaly: results of a 5-year observational, open, prospective study.

Colao A, Auriemma RS, Galdiero M, Cappabianca P, Cavallo LM, Esposito F, Grasso LF, Lombardi G, Pivonello R. Colao A, et al. J Clin Endocrinol Metab. 2009 Feb;94(2):528-37. doi: 10.1210/jc.2008-1546. Epub 2008 Nov 11. J Clin Endocrinol Metab. 2009. PMID: 19001517 Clinical Trial.

5

Glucose tolerance and somatostatin analog treatment in acromegaly: a 12-month study.

Colao A, Auriemma RS, Savastano S, Galdiero M, Grasso LF, Lombardi G, Pivonello R. Colao A, et al. J Clin Endocrinol Metab. 2009 Aug;94(8):2907-14. doi: 10.1210/jc.2008-2627. Epub 2009 Jun 2. J Clin Endocrinol Metab. 2009. PMID: 19491229

6

Somatostatin analogs as a first-line treatment in acromegaly: when is it appropriate?

Grasso LF, Pivonello R, Colao A. Grasso LF, et al. Curr Opin Endocrinol Diabetes Obes. 2012 Aug;19(4):288-94. doi: 10.1097/MED.0b013e328354af67. Curr Opin Endocrinol Diabetes Obes. 2012. PMID: 22627686 Review.

7

Treatment with GH receptor antagonist in acromegaly: effect on cardiac arrhythmias.

Auriemma RS, Pivonello R, De Martino MC, Cudemo G, Grasso LF, Galdiero M, Perone Y, Colao A. Auriemma RS, et al. Eur J Endocrinol. 2012 Dec 10;168(1):15-22. doi: 10.1530/EJE-12-0596. Print 2013 Jan. Eur J Endocrinol. 2012. PMID: 23065994

8

Investigational therapies for acromegaly.

Grasso LF, Pivonello R, Colao A. Grasso LF, et al. Expert Opin Investig Drugs. 2013 Aug;22(8):955-63. doi: 10.1517/13543784.2013.805201. Epub 2013 Jun 3. Expert Opin Investig Drugs. 2013. PMID: 23731031 Review.

9

Somatostatin analogs, cabergoline and pegvisomant: comparing the efficacy of medical treatment for acromegaly.

Grasso LFS, Auriemma RS, Pivonello R, Colao A. Grasso LFS, et al. Expert Rev Endocrinol Metab. 2017 Jan;12(1):73-85. doi: 10.1080/17446651.2016.1222899. Epub 2016 Sep 7. Expert Rev Endocrinol Metab. 2017. PMID: 30058878

10

Acromegaly and Heart Failure.

Colao A, Grasso LFS, Di Somma C, Pivonello R. Colao A, et al. Heart Fail Clin. 2019 Jul;15(3):399-408. doi: 10.1016/j.hfc.2019.03.001. Heart Fail Clin. 2019. PMID: 31079698 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

318 results

Search Page

Filters